CRISPR

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade CRISPR 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. 

CEO
Samarth Kulkarni
CEOSamarth Kulkarni
Employees
393
Employees393
Headquarters
Zug, Zug
HeadquartersZug, Zug
Founded
2013
Founded2013
Employees
393
Employees393

CRSP Key Statistics

Market cap
3.17B
Market cap3.17B
Price-Earnings ratio
-8.49
Price-Earnings ratio-8.49
Dividend yield
Dividend yield
Average volume
1.56M
Average volume1.56M
High today
$38.20
High today$38.20
Low today
$36.80
Low today$36.80
Open price
$37.99
Open price$37.99
Volume
1.60M
Volume1.60M
52 Week high
$68.39
52 Week high$68.39
52 Week low
$36.52
52 Week low$36.52

CRSP News

TipRanks 5d
CRISPR Therapeutics COO Julianne Bruno Resigns

An announcement from Crispr Therapeutics AG ( (CRSP) ) is now available. On March 24, 2025, Julianne Bruno, the Chief Operating Officer of CRISPR Therapeutics,...

Analyst ratings

55%

of 31 ratings
Buy
54.8%
Hold
41.9%
Sell
3.2%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.